Literature DB >> 15565370

IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.

M Hillman1, C Törn, H Thorgeirsson, M Landin-Olsson.   

Abstract

AIMS/HYPOTHESIS: Glutamic acid decarboxylase autoantibodies (GADA) are the most frequent beta-cell-specific autoantibodies in type 1 diabetes and in latent autoimmune diabetes in adults (LADA). The autoimmune attack on pancreatic islet cells is associated with a T helper 1 cell (T(h)1) response, mainly represented by IgG(1)-subclass in humans. It has been proposed that the presence of IgG(4) may be associated with a T(h)2 response. The aim of our study was to compare the GADA IgG-subclass distribution between adult patients with type 1 diabetes and LADA.
METHODS: Patients with type 1 diabetes (n=45) and patients with LADA (n=60) were included. Radioimmunoprecipitation assay with IgG-subclass specific Sepharose (IgG(1), IgG(2), IgG(3) and IgG(4)) was used to precipitate the antibody/antigen-complex.
RESULTS: We only detected IgG(4)-subclass of GADA in subjects with LADA (26.7%; p<0.001). IgG(1) was the most common GADA-subclass in both groups, however IgG(1) as the solely expressed subclass was more common among type 1 diabetic patients (77.8%; p<0.05). The rank order of the frequencies of IgG-subclasses in type 1 diabetes was IgG(1)>IgG(3)>IgG(2)>IgG(4) and in LADA patients IgG(1)>IgG(4)>IgG(2)>IgG(3). CONCLUSIONS/
INTERPRETATION: The difference in GADA IgG-subclasses could indicate a different immune response, possibly an altered balance between T(h)1 and T(h)2 cytokine profile in pancreatic islets. This difference could contribute to the slower rate of beta cell destruction in LADA patients, as reflected by a higher C-peptide level at clinical onset.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565370     DOI: 10.1007/s00125-004-1558-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation.

Authors:  E Bonifacio; M Scirpoli; K Kredel; M Füchtenbusch; A G Ziegler
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

2.  Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients.

Authors:  W Y Ng; A C Thai; K F Lui; P P Yeo; J S Cheah
Journal:  Diabetes Res Clin Pract       Date:  1999-02       Impact factor: 5.602

3.  Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).

Authors:  A Carlsson; G Sundkvist; L Groop; T Tuomi
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

4.  Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse.

Authors:  Kerstin Koczwara; Mike Schenker; Sandra Schmid; Katharina Kredel; Anette-Gabriele Ziegler; Ezio Bonifacio
Journal:  Clin Immunol       Date:  2003-02       Impact factor: 3.969

5.  IgG1 subclass dominates autoimmune response to tyrosine phosphatase-like molecule IA-2 in Chinese type 1 diabetes patients.

Authors:  W Y Ng; K F Lui; J S Cheah; A C Thai
Journal:  Horm Metab Res       Date:  2002-10       Impact factor: 2.936

Review 6.  Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes.

Authors:  A Kukreja; N K Maclaren
Journal:  Cell Mol Life Sci       Date:  2000-04       Impact factor: 9.261

7.  UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.

Authors:  R Turner; I Stratton; V Horton; S Manley; P Zimmet; I R Mackay; M Shattock; G F Bottazzo; R Holman
Journal:  Lancet       Date:  1997-11-01       Impact factor: 79.321

8.  Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis.

Authors:  Maryam Feili-Hariri; Dewayne H Falkner; Andrea Gambotto; Glenn D Papworth; Simon C Watkins; Paul D Robbins; Penelope A Morel
Journal:  Hum Gene Ther       Date:  2003-01-01       Impact factor: 5.695

9.  Reduced IL-4 associated antibody responses to vaccine in early pre-diabetes.

Authors:  S Schmid; A Molteni; M Füchtenbusch; H E Naserke; A-G Ziegler; E Bonifacio
Journal:  Diabetologia       Date:  2002-04-17       Impact factor: 10.122

10.  Suppression of autoimmune diabetes by viral IL-10 gene transfer.

Authors:  Zandong Yang; Meng Chen; Runpei Wu; Lawrence B Fialkow; Jonathan S Bromberg; Marcia McDuffie; Ali Naji; Jerry L Nadler
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

View more
  3 in total

1.  The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.

Authors:  M Hillman; C Törn; M Landin-Olsson
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

2.  Latent Autoimmune Diabetes in Adults: Autoimmune Diabetes in Adults with Slowly Progressive β-cell Failure.

Authors:  Hannah Seok; Byung Wan Lee
Journal:  Diabetes Metab J       Date:  2012-04-17       Impact factor: 5.376

3.  Identification of Sorafenib as a Treatment for Type 1 Diabetes.

Authors:  Qin Zeng; Jianfeng Song; Dandan Wang; Xiaoxiao Sun; Yalun Xiao; Haowei Zhang; Yang Xiao; Zhiguang Zhou; Tuo Deng
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.